Patents by Inventor Woo Ri Ko
Woo Ri Ko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11819526Abstract: A strain of Lactobacillus gasseri KBL697 and the use thereof are described. The strain of Lactobacillus gasseri KBL697 (Accession No. KCTC 13520BP) attenuates allergic reactions of cells, significantly improves symptoms of atopic dermatitis, and exhibits anti-inflammatory and anti-fungal effects and a therapeutic effect for intestinal diseases such as irritable bowel syndrome and colitis. Thus, the single strain alone can achieve all the purposes of alleviating allergic diseases and inflammatory diseases and improving intestinal health, thereby finding advantageous applications as a probiotic substance. In addition, the strain, based on the anti-fungal activity thereof, can be advantageously utilized in a skin external preparation against various skin diseases caused by fungi, and in a cosmetic composition and a functional patch for alleviating sensitive skin.Type: GrantFiled: February 16, 2022Date of Patent: November 21, 2023Assignee: KoBioLabs, Inc.Inventors: Woo Ri Ko, June Chul Lee, Hyo In Park, Tae Wook Nam, Gwang Pyo Ko, Woon Ki Kim, Dae Hee Han, In Su Kim, Jin Woo Lee, Hye Jin Kim
-
Patent number: 11691291Abstract: Disclosed herein are an apparatus and method for generating robot interaction behavior. The method for generating robot interaction behavior includes generating co-speech gesture of a robot corresponding to utterance input of a user, generating a nonverbal behavior of the robot, that is a sequence of next joint positions of the robot, which are estimated from joint positions of the user and current joint positions of the robot based on a pre-trained neural network model for robot pose estimation, and generating a final behavior using at least one of the co-speech gesture and the nonverbal behavior.Type: GrantFiled: November 27, 2020Date of Patent: July 4, 2023Assignee: Electronics and Telecommunications Research InstituteInventors: Woo-Ri Ko, Do-Hyung Kim, Jae-Hong Kim, Young-Woo Yoon, Jae-Yeon Lee, Min-Su Jang
-
Patent number: 11633439Abstract: A strain of Lactobacillus crispatus KBL693 and the use thereof are disclosed. The strain of Lactobacillus crispatus KBL693 (Accession No. KCTC 13519BP) attenuates allergic reactions of cells, significantly improves symptoms of atopic dermatitis, and exhibits anti-inflammatory and anti-fungal effects. Thus, the single strain alone can achieve all the purposes of alleviating atopic dermatitis and other allergic diseases and improving inflammatory diseases and autoimmune diseases, thereby finding advantageous applications as a probiotic substance. In addition, the strain, based on the anti-fungal activity thereof, can be advantageously utilized in a skin external preparation against various skin diseases caused by fungi, and in a cosmetic composition and a functional patch for alleviating sensitive skin.Type: GrantFiled: September 23, 2021Date of Patent: April 25, 2023Assignee: KoBioLabs, Inc.Inventors: Woo Ri Ko, June Chul Lee, Tae-Wook Nam, Gwang Pyo Ko, Hyun Ju You, So Yon Yoon, Seok Cheon Song
-
Publication number: 20220175858Abstract: A strain of Lactobacillus gasseri KBL697 and the use thereof are described. The strain of Lactobacillus gasseri KBL697 (Accession No. KCTC 13520BP) attenuates allergic reactions of cells, significantly improves symptoms of atopic dermatitis, and exhibits anti-inflammatory and anti-fungal effects and a therapeutic effect for intestinal diseases such as irritable bowel syndrome and colitis. Thus, the single strain alone can achieve all the purposes of alleviating allergic diseases and inflammatory diseases and improving intestinal health, thereby finding advantageous applications as a probiotic substance. In addition, the strain, based on the anti-fungal activity thereof, can be advantageously utilized in a skin external preparation against various skin diseases caused by fungi, and in a cosmetic composition and a functional patch for alleviating sensitive skin.Type: ApplicationFiled: February 16, 2022Publication date: June 9, 2022Inventors: Woo Ri Ko, June Chul Lee, Hyo In Park, Tae Wook Nam, Gwang Pyo Ko, Woon Ki Kim, Dae Hee Han, In Su Kim, Jin Woo Lee, Hye Jin Kim
-
Patent number: 11285183Abstract: A strain of Lactobacillus gasseri KBL697 and the use thereof are described. The strain of Lactobacillus gasseri KBL697 (Accession No. KCTC 13520BP) attenuates allergic reactions of cells, significantly improves symptoms of atopic dermatitis, and exhibits anti-inflammatory and anti-fungal effects and a therapeutic effect for intestinal diseases such as irritable bowel syndrome and colitis. Thus, the single strain alone can achieve all the purposes of alleviating allergic diseases and inflammatory diseases and improving intestinal health, thereby finding advantageous applications as a probiotic substance. In addition, the strain, based on the anti-fungal activity thereof, can be advantageously utilized in a skin external preparation against various skin diseases caused by fungi, and in a cosmetic composition and a functional patch for alleviating sensitive skin.Type: GrantFiled: November 23, 2020Date of Patent: March 29, 2022Assignee: KoBioLabs, Inc.Inventors: Woo Ri Ko, June Chul Lee, Hyo In Park, Tae Wook Nam, Gwang Pyo Ko, Woon Ki Kim, Dae Hee Han, In Su Kim, Jin Woo Lee, Hye Jin Kim
-
Publication number: 20220055221Abstract: Disclosed herein are an apparatus and method for generating robot interaction behavior. The method for generating robot interaction behavior includes generating co-speech gesture of a robot corresponding to utterance input of a user, generating a nonverbal behavior of the robot, that is a sequence of next joint positions of the robot, which are estimated from joint positions of the user and current joint positions of the robot based on a pre-trained neural network model for robot pose estimation, and generating a final behavior using at least one of the co-speech gesture and the nonverbal behavior.Type: ApplicationFiled: November 27, 2020Publication date: February 24, 2022Applicant: Electronics and Telecommunications Research InstituteInventors: Woo-Ri KO, Do-Hyung KIM, Jae-Hong KIM, Young-Woo YOON, Jae-Yeon LEE, Min-Su JANG
-
Publication number: 20220000951Abstract: A strain of Lactobacillus crispatus KBL693 and the use thereof are disclosed. The strain of Lactobacillus crispatus KBL693 (Accession No. KCTC 13519BP) attenuates allergic reactions of cells, significantly improves symptoms of atopic dermatitis, and exhibits anti-inflammatory and anti-fungal effects. Thus, the single strain alone can achieve all the purposes of alleviating atopic dermatitis and other allergic diseases and improving inflammatory diseases and autoimmune diseases, thereby finding advantageous applications as a probiotic substance. In addition, the strain, based on the anti-fungal activity thereof, can be advantageously utilized in a skin external preparation against various skin diseases caused by fungi, and in a cosmetic composition and a functional patch for alleviating sensitive skin.Type: ApplicationFiled: September 23, 2021Publication date: January 6, 2022Inventors: Woo Ri Ko, June Chul Lee, Tae-Wook Nam, Gwang Pyo Ko, Hyun Jun You, So Yon Yoon, Seok Cheon Song
-
Patent number: 11141444Abstract: A strain of Lactobacillus crispatus KBL693 and the use thereof are disclosed. The strain of Lactobacillus crispatus KBL693 (Accession No. KCTC 13519BP) attenuates allergic reactions of cells, significantly improves symptoms of atopic dermatitis, and exhibits anti-inflammatory and anti-fungal effects. Thus, the single strain alone can achieve all the purposes of alleviating atopic dermatitis and other allergic diseases and improving inflammatory diseases and autoimmune diseases, thereby finding advantageous applications as a probiotic substance. In addition, the strain, based on the anti-fungal activity thereof, can be advantageously utilized in a skin external preparation against various skin diseases caused by fungi, and in a cosmetic composition and a functional patch for alleviating sensitive skin.Type: GrantFiled: November 23, 2020Date of Patent: October 12, 2021Assignee: KO Biolabs, Inc.Inventors: Woo Ri Ko, June Chul Lee, Tae-Wook Nam, Gwang Pyo Ko, Hyun Ju You, So Yon Yoon, Seok Cheon Song
-
Publication number: 20210106631Abstract: A strain of Lactobacillus crispatus KBL693 and the use thereof are disclosed. The strain of Lactobacillus crispatus KBL693 (Accession No. KCTC 13519BP) attenuates allergic reactions of cells, significantly improves symptoms of atopic dermatitis, and exhibits anti-inflammatory and anti-fungal effects. Thus, the single strain alone can achieve all the purposes of alleviating atopic dermatitis and other allergic diseases and improving inflammatory diseases and autoimmune diseases, thereby finding advantageous applications as a probiotic substance. In addition, the strain, based on the anti-fungal activity thereof, can be advantageously utilized in a skin external preparation against various skin diseases caused by fungi, and in a cosmetic composition and a functional patch for alleviating sensitive skin.Type: ApplicationFiled: November 23, 2020Publication date: April 15, 2021Inventors: Woo Ri Ko, June Chul Lee, Tae-Wook Nam, Gwang Pyo Ko, Hyun Ju You, So Yon Yoon, Seok Cheon Song
-
Publication number: 20210093682Abstract: A strain of Lactobacillus gasseri KBL697 and the use thereof are described. The strain of Lactobacillus gasseri KBL697 (Accession No. KCTC 13520BP) attenuates allergic reactions of cells, significantly improves symptoms of atopic dermatitis, and exhibits anti-inflammatory and anti-fungal effects and a therapeutic effect for intestinal diseases such as irritable bowel syndrome and colitis. Thus, the single strain alone can achieve all the purposes of alleviating allergic diseases and inflammatory diseases and improving intestinal health, thereby finding advantageous applications as a probiotic substance. In addition, the strain, based on the anti-fungal activity thereof, can be advantageously utilized in a skin external preparation against various skin diseases caused by fungi, and in a cosmetic composition and a functional patch for alleviating sensitive skin.Type: ApplicationFiled: November 23, 2020Publication date: April 1, 2021Inventors: Woo Ri Ko, June Chul Lee, Hyo In Park, Tae Wook Nam, Gwang Pyo Ko, Woon Ki Kim, Dae Hee Han, In Su Kim, Jin Woo Lee, Hye Jin Kim